News
Sun Pharma announces FDA tentative approval for generic Cymbalta
Sun Pharmaceutical Industries Ltd. announced US FDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a generic...
News
Lilly and Acrux Receive FDA Approval for Axiron Topical...
Eli Lilly and Company and Acrux announced that the U.S. FDA has approved Axiron topical solution CIII for replacement therapy in men for certain conditions...
News
VYTORIN the cholesterol-lowering medicine from Merck
In a new investigational study of VYTORIN, the cholesterol-lowering medicine from Merck (known as MSD outside the US and Canada), VYTORIN 10/20 mg reduced the...
News
Antares Pharma Announces Next Generation of Auto-Injector Design
Antares Pharma, Inc., a leader in self-injection drug delivery technology, announced the latest advancement in its proprietary line of VIBEX(TM) auto-injectors. Antares'...
News
Pfizer Announces Positive Phase 3 Trial Results for Axitinib
Pfizer Inc.announced that the Phase 3 AXIS 1032 trial (A4061032), studying the investigational compound axitinib in previously treated patients with metastatic renal cell carcinoma (mRCC),...
News
Britannia innovates to provide Lifestyle Management Solutions for Diabetes
Britannia Industries Limited, one of India’s leading Food companies, has over the last 2 years demonstrated significant initiatives in the Health and Wellness space. Its...
News
Eisai Inc. Received U.S Food and Drug Administration for...
Eisai Inc. announced that the United States Food and Drug Administration (FDA) has approved Halaven™ (eribulin mesylate) Injection for the treatment of patients with metastatic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.